Kodiak Sciences, Inc. (KOD)
99.70
+5.44
(+5.77%)
USD |
NASDAQ |
Oct 09, 13:23
Kodiak Sciences Net Income (Quarterly) : -65.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -65.64M |
| March 31, 2026 | -58.16M |
| December 31, 2025 | -56.74M |
| September 30, 2025 | -61.46M |
| June 30, 2025 | -54.31M |
| March 31, 2025 | -57.46M |
| December 31, 2024 | -44.10M |
| September 30, 2024 | -43.95M |
| June 30, 2024 | -45.12M |
| March 31, 2024 | -43.04M |
| December 31, 2023 | -59.52M |
| September 30, 2023 | -50.01M |
| June 30, 2023 | -80.19M |
| March 31, 2023 | -70.78M |
| December 31, 2022 | -70.45M |
| September 30, 2022 | -77.04M |
| June 30, 2022 | -90.63M |
| March 31, 2022 | -95.71M |
| Date | Value |
|---|---|
| December 31, 2021 | -93.16M |
| September 30, 2021 | -67.53M |
| June 30, 2021 | -55.85M |
| March 31, 2021 | -50.45M |
| December 31, 2020 | -46.58M |
| September 30, 2020 | -36.12M |
| June 30, 2020 | -26.00M |
| March 31, 2020 | -24.39M |
| December 31, 2019 | -15.62M |
| September 30, 2019 | -12.38M |
| June 30, 2019 | -11.38M |
| March 31, 2019 | -7.984M |
| December 31, 2018 | -14.66M |
| September 30, 2018 | -10.45M |
| March 31, 2018 | -8.92M |
| December 31, 2017 | -11.57M |
| September 30, 2017 | -4.583M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.297B |
| AbbVie, Inc. | 3.604B |
| Mirum Pharmaceuticals, Inc. | -67.23M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 65.64M |
| EPS Diluted (Quarterly) | -1.048 |
| Enterprise Value | 5.949B |
| Earnings Yield | -4.21% |
| Normalized Earnings Yield | -4.206 |